(RLGT) Radiant Logistics - Overview
Stock: Freight Forwarding, Customs Brokerage, Supply Chain, Intermodal
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -6.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -13.81 |
| Character TTM | |
|---|---|
| Beta | 0.830 |
| Beta Downside | 0.735 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.53% |
| CAGR/Max DD | 0.20 |
Description: RLGT Radiant Logistics December 31, 2025
Radiant Logistics, Inc. (NYSE MKT: RLGT) is a third-party logistics provider that leverages a proprietary technology platform to coordinate global transportation across air, ocean, truckload, less-than-truckload and intermodal modes in the United States and Canada.
The firm’s service suite extends beyond freight forwarding and brokerage to include customs brokerage, materials management, distribution, and end-to-end trade compliance for a diversified client base that spans consumer goods, food & beverage, electronics, high-tech, aviation, automotive, military, government, manufacturing and retail sectors.
Key operational metrics from the most recent filing show FY 2023 revenue of $126 million, a 9 % year-over-year increase driven primarily by higher e-commerce volumes, and an adjusted EBITDA margin of roughly 6 %, reflecting modest scale efficiencies but also elevated labor and fuel costs.
Sector-wide, the North American air freight and logistics market is currently being shaped by three macro drivers: (1) sustained e-commerce demand that lifts small-package and air-freight volumes, (2) ongoing carrier capacity constraints that keep spot rates above historical averages, and (3) a tight labor market that pressures operating margins for asset-light brokers like Radiant.
For a deeper quantitative breakdown, the ValueRay platform offers a ready-made model that can help you stress-test RLGT’s exposure to these drivers.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 15.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 2.09 > 1.0 |
| NWC/Revenue: 7.98% < 20% (prev 6.17%; Δ 1.80% < -1%) |
| CFO/TA 0.03 > 3% & CFO 15.5m > Net Income 15.2m |
| Net Debt (64.1m) to EBITDA (33.3m): 1.92 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.7m) vs 12m ago 0.31% < -2% |
| Gross Margin: 15.97% > 18% (prev 0.17%; Δ 1580 % > 0.5%) |
| Asset Turnover: 225.6% > 50% (prev 211.9%; Δ 13.72% > 0%) |
| Interest Coverage Ratio: 9.49 > 6 (EBITDA TTM 33.3m / Interest Expense TTM 1.71m) |
Altman Z'' 3.18
| A: 0.17 (Total Current Assets 195.3m - Total Current Liabilities 121.4m) / Total Assets 445.3m |
| B: 0.34 (Retained Earnings 151.9m / Total Assets 445.3m) |
| C: 0.04 (EBIT TTM 16.2m / Avg Total Assets 410.3m) |
| D: 0.68 (Book Value of Equity 147.7m / Total Liabilities 218.2m) |
| Altman-Z'' Score: 3.18 = A |
Beneish M -2.82
| DSRI: 1.02 (Receivables 153.8m/129.5m, Revenue 925.8m/795.2m) |
| GMI: 1.08 (GM 15.97% / 17.19%) |
| AQI: 1.01 (AQ_t 0.39 / AQ_t-1 0.38) |
| SGI: 1.16 (Revenue 925.8m / 795.2m) |
| TATA: -0.00 (NI 15.2m - CFO 15.5m) / TA 445.3m) |
| Beneish M-Score: -2.82 (Cap -4..+1) = A |
What is the price of RLGT shares?
Over the past week, the price has changed by +1.00%, over one month by +5.23%, over three months by +13.37% and over the past year by -0.14%.
Is RLGT a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RLGT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.3 | 18.3% |
| Analysts Target Price | 8.3 | 18.3% |
| ValueRay Target Price | 7.5 | 5.8% |
RLGT Fundamental Data Overview February 03, 2026
P/E Forward = 11.6822
P/S = 0.3407
P/B = 1.4109
P/EG = 0.78
Revenue TTM = 925.8m USD
EBIT TTM = 16.2m USD
EBITDA TTM = 33.3m USD
Long Term Debt = 30.0m USD (from longTermDebt, last quarter)
Short Term Debt = 13.2m USD (from shortTermDebt, last quarter)
Debt = 92.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 64.1m USD (from netDebt column, last quarter)
Enterprise Value = 379.5m USD (315.5m + Debt 92.2m - CCE 28.1m)
Interest Coverage Ratio = 9.49 (Ebit TTM 16.2m / Interest Expense TTM 1.71m)
EV/FCF = 34.58x (Enterprise Value 379.5m / FCF TTM 11.0m)
FCF Yield = 2.89% (FCF TTM 11.0m / Enterprise Value 379.5m)
FCF Margin = 1.19% (FCF TTM 11.0m / Revenue TTM 925.8m)
Net Margin = 1.64% (Net Income TTM 15.2m / Revenue TTM 925.8m)
Gross Margin = 15.97% ((Revenue TTM 925.8m - Cost of Revenue TTM 777.9m) / Revenue TTM)
Gross Margin QoQ = 16.71% (prev 17.46%)
Tobins Q-Ratio = 0.85 (Enterprise Value 379.5m / Total Assets 445.3m)
Interest Expense / Debt = 0.66% (Interest Expense 605.0k / Debt 92.2m)
Taxrate = 21.00% (339.0k / 1.61m)
NOPAT = 12.8m (EBIT 16.2m * (1 - 21.00%))
Current Ratio = 1.61 (Total Current Assets 195.3m / Total Current Liabilities 121.4m)
Debt / Equity = 0.41 (Debt 92.2m / totalStockholderEquity, last quarter 225.7m)
Debt / EBITDA = 1.92 (Net Debt 64.1m / EBITDA 33.3m)
Debt / FCF = 5.84 (Net Debt 64.1m / FCF TTM 11.0m)
Total Stockholder Equity = 221.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.71% (Net Income 15.2m / Total Assets 445.3m)
RoE = 6.88% (Net Income TTM 15.2m / Total Stockholder Equity 221.1m)
RoCE = 6.46% (EBIT 16.2m / Capital Employed (Equity 221.1m + L.T.Debt 30.0m))
RoIC = 5.40% (NOPAT 12.8m / Invested Capital 237.3m)
WACC = 7.06% (E(315.5m)/V(407.6m) * Re(8.97%) + D(92.2m)/V(407.6m) * Rd(0.66%) * (1-Tc(0.21)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.17%
[DCF Debug] Terminal Value 74.73% ; FCFF base≈7.14m ; Y1≈4.69m ; Y5≈2.14m
Fair Price DCF = N/A (negative equity: EV 50.4m - Net Debt 64.1m = -13.7m; debt exceeds intrinsic value)
EPS Correlation: -77.92 | EPS CAGR: -57.42% | SUE: -1.51 | # QB: 0
Revenue Correlation: -73.82 | Revenue CAGR: -9.95% | SUE: 0.89 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=-0.004 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-06-30): EPS=0.27 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=-58.5% | Growth Revenue=+1.8%
EPS next Year (2027-06-30): EPS=0.34 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+27.0% | Growth Revenue=+3.6%